amezinium has been researched along with Multiple System Atrophy Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akaogi, Y; Asahina, M; Hattori, T; Koyama, Y; Yamanaka, Y | 1 |
| Asahina, M; Hattori, T; Sakakibara, R; Uchiyama, T; Yamanishi, T; Yoshiyama, M | 1 |
2 other study(ies) available for amezinium and Multiple System Atrophy Syndrome
| Article | Year |
|---|---|
Differences in skin sympathetic involvements between two chronic autonomic disorders: multiple system atrophy and pure autonomic failure.
Topics: Aged; Autonomic Nervous System Diseases; Blood Flow Velocity; Blood Pressure; Female; Fludrocortisone; Humans; Hypotension, Orthostatic; Male; Mathematics; Mental Processes; Middle Aged; Midodrine; Multiple System Atrophy; Parkinson Disease; Pyridazines; Reference Values; Skin; Sweating; Sympathetic Nervous System; Sympathomimetics | 2009 |
Amezinium metilsulfate, a sympathomimetic agent, may increase the risk of urinary retention in multiple system atrophy.
Topics: Aged; Female; Humans; Male; Middle Aged; Multiple System Atrophy; Pyridazines; Retrospective Studies; Sympathomimetics; Urinary Retention; Urodynamics | 2003 |